Evidence map›Paper›PMID 25604473›Full record

ArticleMalaria journal2015

Measuring naturally acquired ex vivo IFN-γ responses to Plasmodium falciparum cell-traversal protein for ookinetes and sporozoites (CelTOS) in Ghanaian adults.

Dorothy Anum, Kwadwo A Kusi, Harini Ganeshan, Michael R Hollingdale, Michael F Ofori, Kwadwo A Koram, Ben A Gyan, Susan Adu-Amankwah, Edem Badji, Jun Huang and 6 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. A Balanced Proinflammatory and Regulatory Cytokine Signature in Young African Children Is Associated With Lower Risk of Clinical Malaria.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Trial
  2. Article
  3. Article
  4. In Silico Analysis Reveals High Levels of Genetic Diversity ofTropical medicine and infectious disease · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Comprehensive Review of HumanFrontiers in immunology · 2019
    Review
  11. Immune Responses in Malaria.Cold Spring Harbor perspectives in medicine · 2017
    Review
  12. Article
  13. Frontiers in immunology · 2017
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Dorothy Anum
Kwadwo A KusiNoguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana. akusi@noguchi.ug.edu.gh.
Harini Ganeshan
Michael R Hollingdale
Michael F Ofori
Kwadwo A Koram
Ben A Gyan
Susan Adu-Amankwah
Edem Badji
Jun Huang
Maria Belmonte
Glenna J Banania
Theophilus B Kwofie
Eileen Villasante
Daniel Dodoo
Martha Sedegah
Naval Medical Research Command · USNoguchi Memorial Institute for Medical Research · GHUniversity of Ghana · GHKwame Nkrumah University of Science and Technology · GH

Funding

MALARIA--ENDEMIC AREA CLIN RESEARCH &TRIAL PREP SITE-266995363N01AI095363 · NIAID · UNIVERSITY OF GHANA · 1999 to 2004
–
NIAID NIH HHS N01 AI95363
6 · The paper itself

Abstract

backgroundA malaria vaccine that targets the sporozoite/liver stage parasites could potentially prevent blood stage infection and the associated clinical symptoms. Identification of sporozoite/liver stage antigens is, therefore, crucial for the development of effective vaccines. Cell-traversal protein for ookinetes and sporozoites (CelTOS) is a highly conserved antigen involved in sporozoite motility and hepatocyte invasion and has been shown to induce significant IFN-γ production in PBMCs from radiation-attenuated sporozoite-immunized malaria-naïve individuals. The aim of this study was to ascertain whether such CelTOS-specific recall responses are also induced in individuals with natural exposure to Plasmodium falciparum.

methodsEx vivo IFN-γ responses to 15mer overlapping peptide pools covering the entire sequence of CelTOS and five other candidate antigens, CSP, AMA1, MSP1, TRAP and LSA1, were characterized using PBMCs from 35 malaria exposed adults. Responses to four CelTOS peptide pools (CelTp1, CelTp2, CelTp3 and CelTp4), a pool containing peptides from the entire CelTOS antigen (CelTTp), and pools comprised of overlapping peptides from each of the other five malaria antigens were assessed by ex vivo ELISpot assay. A positive IFN-γ response for stimulants was defined by two criteria; a stimulation index of two or greater relative to the unstimulated control, and a difference of 10 or greater in spot forming cells between stimulant and the unstimulated control.

resultsOf the 35 volunteers tested, five had positive IFN-γ recall responses against the four different CelTOS pools while four volunteers made responses against the CelTTp pool; six volunteers were, therefore, positive with CelTOS. By contrast, six volunteers responded to AMA1, seven to LSA1, 15 to MSP1 and two volunteers responded against CSP and TRAP.

conclusionsThese results suggest natural malaria transmission induces CelTOS-specific ex vivo IFN-γ in Ghanaian adults and that the frequency of these responses was similar to those of other previously characterized malaria antigens. These findings support the further evaluation of CelTOS as a pre-erythrocytic candidate antigen for inclusion in a potential multi-antigen vaccine.

Indexed as

AdultAntigens, ProtozoanEnzyme-Linked Immunospot AssayFemaleGhanaHumansInterferon-gammaLeukocytes, MononuclearMalePlasmodium falciparumProtozoan ProteinsSporozoitesAntigens, ProtozoanInterferon-gammaProtozoan Proteins

Identifiers

PMID25604473
PMCPMC4308902
OpenAlexW2156525446

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.